TLX
Telix Pharmaceuticals Limited American Depositary Receipt (TLX)
Market Closed
12 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
9. 02
-0.35
-3.74%
$
3.32B Market Cap
- P/E Ratio
0% Div Yield
230,848 Volume
- Eps
$ 9.37
Previous Close Day Range
8.99 9.42
Year Range
8.76 30.36
Want to track TLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 66 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| TLX TLX Telix Pharmaceuticals Limited American Depositary Receipt 18 Feb 2026 (In 2 months) | | - | - |
| TLX TLX Telix Pharmaceuticals Limited American Depositary Receipt 23 Oct 2025 | | - | - |
| TLX TLX Telix Pharmaceuticals Limited American Depositary Receipt 20 Aug 2025 | | - | 0.01 |
TLX Earnings Reports FAQ
What is the earnings per share (EPS) for TLX?
EPS data for TLX is currently not available, as Telix Pharmaceuticals Limited American Depositary Receipt has not reported recent earnings.
What is the company's earnings growth rate?
Telix Pharmaceuticals Limited American Depositary Receipt has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-18, based on the TLX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Telix Pharmaceuticals Limited American Depositary Receipt are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TLX at this time, as Telix Pharmaceuticals Limited American Depositary Receipt has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
